Clark Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$423K Buy
353
+10
+3% +$10.2K 0.24% 47
2026
Q1
$315K Sell
343
-10
-3% -$10.1K 0.21% 44
2025
Q4
$379K Hold
353
0.23% 49
2025
Q3
$379K Buy
353
+322
+1,039% +$240K 0.23% 49
2025
Q2
$24.2K Sell
31
-1
-3% -$777 0.02% 148
2025
Q1
$26.4K Sell
32
-8
-20% -$6.66K 0.02% 136
2024
Q4
$30.9K Buy
+40
New +$33.1K 0.02% 111

Other funds holding LLY

Clark Wealth Partners's LLY Position: Q2 2026 in Review

Clark Wealth Partners increased its Eli Lilly (LLY) stake by 2.9% in Q2 2026, buying an estimated $10.2K and bringing the position to 353 shares worth $423K. The position accounts for 0.24% of the portfolio, ranked #47.

Clark Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clark Wealth Partners held 353 shares of Eli Lilly worth $423K as of Q2 2026.
  • Clark Wealth Partners bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.24% of Clark Wealth Partners's portfolio in Q2 2026, its #47 holding.
  • Clark Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.